二脒那秦激活ACE2对非酒精性脂肪肝病大鼠肝线粒体影响研究

doi:10.11843/j.issn.0366-6964.2023.09.028

摘要/Abstract

摘要： 旨在通过建立高脂饮食诱导的非酒精性脂肪肝病(non-alcoholic fatty liver disease, NAFLD)模型,研究二脒那秦(DIZE)激活血管紧张素转换酶2(ACE2)对线粒体结构和功能的影响。试验选取26只雄性SD大鼠,随机选取9只大鼠饲喂普通饲料作为对照组(CON组),其余大鼠饲喂高脂饲料进行造模,4周后,随机各取1只进行处理,经病理组织学检查确认成功建立NAFLD模型。造模成功的大鼠随机分为模型组(MOD组)和二脒那秦组(DIZE组)(每组8只),MOD组继续饲喂高脂饲料同时灌胃3 mL·d^-1生理盐水,DIZE组饲喂高脂饲料并灌胃15 mg·(kg·d)^-1 DIZE,CON组继续饲喂普通饲料并灌胃等量生理盐水。试验至第10周,采集大鼠血清和肝组织样品进行试验:1)检测血清中TG、TC含量;2)ELISA 法测定肝组织中AngⅡ和 Ang1-7含量;3)Western blot法检测ACE2,线粒体融合蛋白(Mfn1、OPA1),分裂蛋白(Fis1、Drp1)及解偶联蛋白1(UCP1)的蛋白表达水平;4)RT-qPCR法检测线粒体生物发生和线粒体呼吸链复合物相关基因的mRNA表达水平。结果表明:1)高脂饲料饲喂4周后大鼠HE染色肝脏出现明显的脂肪沉积,成功建立NAFLD模型;2)与 CON 组相比,MOD 组大鼠血清中的TG、TC含量显著升高(P<0.05),DIZE组则较MOD组显著降低(P<0.05);3)与 CON 组相比,MOD 组ACE2蛋白表达水平极显著降低(P<0.01),AngⅡ/Ang1-7比值显著升高(P<0.05),DIZE组则较MOD组ACE2蛋白表达水平极显著升高,AngⅡ/Ang1-7比值极显著降低(P<0.01);4)与 CON 组相比,MOD 组线粒体融合、分裂及UCP1蛋白表达水平极显著或显著降低(P<0.01或P<0.05),DIZE组则较MOD组极显著升高(P<0.01);5)与 CON 组相比,MOD 组线粒体生物发生和线粒体呼吸链复合物Ⅰ和Ⅲ基因mRNA表达水平极显著下调(P<0.01),DIZE组则较MOD组极显著或显著上调(P<0.01或P<0.05)。综上表明,DIZE能够激活ACE2继而缓解由高脂饮食引起的对线粒体生物发生、融合、分裂以及呼吸链相关指标的抑制作用,从而达到治疗NAFLD 的效果。本研究为DIZE治疗NAFLD提供新思路,DIZE作为老药新用具有潜在的研究价值。

关键词: 二脒那秦(DIZE), 非酒精性脂肪肝病, 血管紧张素转换酶2(ACE2), 线粒体, 大鼠

Abstract: The article aims to study the effects of diminazene aceturate (DIZE) activation of Angiotensin-converting enzyme 2 (ACE2) on mitochondrial structure and function by establishing a high-fat diet-induced non-alcoholic fatty liver disease(NAFLD) model. Twenty-six male SD rats were selected, nine rats were fed with basal feed as a contral group, the remaining rats were fed with high-fat feed for modeling. After 4 weeks, the NAFLD model was successfully established by the confirmation of pathohistological examination. Then, the rats with successful modeling were randomly divided into Model group and DIZE group(eight rats per group),Model group rats were continued to be fed hight-fat feed and treated with 3 mL saline by intragastric administration, DIZE group rats were treated with 15 mg·(kg·d)^-1 DIZE as gavage. The contral group continued to be fed with common feed, and the same amount of normal saline was gavage administered. In the tenth week, serum and liver samples were collected from rats for the following tests:1) The kit was used to detect TG and TC content in serum; 2)The content of AngII and Ang1-7 in liver tissues were determined by ELISA; 3) Western blotting method was used to test the protein expression of ACE2, mitochondrial fusion protein (Mfn1, OPA1), fission protein (Fis1, Drp1) and uncoupling protein 1 (UCP1); 4) RT-qPCR to test mRNA expression of mitochondrial biogenesis and mitochondrial respiratory chain complex-related genes. Results:1) The fat deposition was found in HE staining after 4 weeks of high-fat feeding, obviously, which indicates that the NAFLD modeling of rats was successfully established; 2) Compared with the CON group, the serum levels of TG and TC in the MOD group rats were significantly higher (P<0.05), while the DIZE group was significantly lower (P<0.05) compared with the MOD group; 3) Compared with CON group, ACE2 protein expression level in MOD group was extremely significant decreased (P<0.01), and the ratio of AngⅡ/Ang1-7 was significantly increased (P<0.05), however, compared with model group, the results were opposite in DIZE group (P<0.01); 4) The expression levels of fusion, fission and UCP1 protein were significantly or extremely significant reduced in model group compared to the control group (P<0.01 or P<0.05), DIZE could upregulate the expression levels of fusion, fission and UCP1 protein extremely(P<0.01); 5) Compared with the CON group, the expression levels of mRNA in mitochondrial biogenesis and mitochondrial respiratory chain complex I and III genes were extremely significant downregulated in the MOD group (P<0.01), nevertheless, compared with model group, DIZE group shows the opposite results(P<0.01 or P<0.05). The results demonstrated that DIZE could activate ACE2, thereby alleviating the inhibitory effects on mitochondrial biogenesis, fusion, fission, and respiratory chain-related parameters induced by a high-fat diet, ultimately achieving therapeutic effects for NAFLD. This study elucidates a new idea of DIZE for the treatment of non-alcoholic fatty liver disease, which manifests DIZE has potential research value as a new use of an old drug.

Key words: diminazene aceturate (DIZE), non-alcoholic fatty liver disease, angiotensin-converting enzyme 2 (ACE2), mitochondria, rat

中图分类号:

S852.2

张亚峰, 朱斌, 马畅, 张源淑. 二脒那秦激活ACE2对非酒精性脂肪肝病大鼠肝线粒体影响研究[J]. 畜牧兽医学报, 2023, 54(9): 3895-3904.

ZHANG Yafeng, ZHU Bin, MA Chang, ZHANG Yuanshu. The Research on the Effects of ACE2 Activated by Diminazene Aceturate on Mitochondria in the Liver of Rats with Non-alcoholic Fatty Liver Disease[J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(9): 3895-3904.

参考文献

[1] CABALLERIA L, TORÁN P. Epidemia de esteatosis hepática:un análisis desde la atención primaria[J]. Aten Primaria, 2019, 51(9):525-526.
[2] AL MARUF A, O'BRIEN P J, NASERZADEH P, et al. Methotrexate induced mitochondrial injury and cytochrome c release in rat liver hepatocytes[J]. Drug Chem Toxicol, 2018, 41(1):51-61.
[3] YEH M M, BRUNT E M. Pathological features of fatty liver disease[J]. Gastroenterology, 2014, 147(4):754-764.
[4] FOURET G, GAILLET S, LECOMTE J, et al. 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat-high-fructose diet[J]. Br J Nutr, 2018, 119(4):368-380.
[5] MEEX R C R, BLAAK E E. Mitochondrial dysfunction is a key pathway that links saturated fat intake to the development and progression of NAFLD[J]. Mol Nutr Food Res, 2021, 65(1):1900942.
[6] DELPINO M V, QUARLERI J. SARS-CoV-2 Pathogenesis:imbalance in the renin-angiotensin system favors lung fibrosis[J]. Front Cell Infect Microbiol, 2020, 10:340.
[7] SONG L N, LIU J Y, SHI T T, et al. Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism[J]. FASEB J, 2020, 34(12):16291-16306.
[8] ZHAO Q, ZHOU X S, KUIPER R, et al. Mitochondrial dysfunction is associated with lipid metabolism disorder and upregulation of angiotensin-converting enzyme 2[J]. PLoS One, 2022, 17(6):e0270418.
[9] CAO X, YANG F Y, SHI T T, et al. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis[J]. Sci Rep, 2016, 6:21592.
[10] CAO X, YANG F Y, XIN Z, et al. The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance[J]. Mol Cell Endocrinol, 2014, 393(1-2):30-38.
[11] CAO X, SONG L N, ZHANG Y C, et al. Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease[J]. Diabetes Metab Res Rev, 2019, 35(4):e3123.
[12] MORAES D S, DE FARIAS LELIS D, ANDRADE J M O, et al. Enalapril improves obesity associated liver injury ameliorating systemic metabolic markers by modulating Angiotensin Converting Enzymes ACE/ACE2 expression in high-fat feed mice[J]. Prostaglandins Other Lipid Mediat, 2021, 152:106501.
[13] KULEMINA L V, OSTROV D A. Prediction of off-target effects on angiotensin-converting enzyme 2[J]. J Biomol Screen, 2011, 16(8):878-885.
[14] 何晟. 二脒那秦对高脂饮食诱导的非酒精性脂肪肝病大鼠脂类代谢的影响[D]. 南京:南京农业大学, 2020.
HE S. Effect of diminazene on lipid metabolism in rats with non-alcoholic fatty liver disease induced by high-fat diet[D]. Nanjing:Nanjing Agricultural University, 2020. (in Chinese)
[15] 朱斌, 何晟, 付亚丽, 等. 二乙酰胺三氮脒对大鼠非酒精性脂肪肝病的作用初步分析[J]. 中国农业大学学报, 2021, 26(7):85-95.
ZHU B, HE S, FU Y L, et al. Preliminary exploration of the effect of diminazene aceturate on nonalcoholic fatty liver disease in rats[J]. Journal of China Agricultural University, 2021, 26(7):85-95. (in Chinese)
[16] WANG K, LIU X Q, XIAO H, et al. The correlation between inflammatory injury induced by LPS and RAS in EpH4-Ev cells[J]. Int Immunopharmacol, 2017, 46:23-30.
[17] CHALASANI N, YOUNOSSI Z, LAVINE J E, et al. The diagnosis and management of nonalcoholic fatty liver disease:practice guidance from the American association for the study of liver diseases[J]. Hepatology, 2018, 67(1):328-357.
[18] ZHAO W H, XU W M. Glutaredoxin 2(GRX2) deficiency exacerbates high fat diet (HFD)-induced insulin resistance, inflammation and mitochondrial dysfunction in brain injury:a mechanism involving GSK-3β[J]. Biomed Pharmacother, 2019, 118:108940.
[19] FELTENBERGER J D, ANDRADE J M O, PARAÍSO A, et al. Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice[J]. Hypertension, 2013, 62(2):324-330.
[20] NTOUMA V, HARALAMBOUS C. Liver-specific deletion of the mitochondrial stress UBL-5 gene leads to fatty liver that is rescued by pioglitazone administration or ACE2 overexpression[J]. Diabetes, 2018, 67(S1):253-LB.
[21] 曹西月, 付亚丽, 谢娜娜,等. 二脒那秦内源性激活血管紧张素转化酶2对细胞脂质沉积的抑制效应及其机制[J]. 畜牧兽医学报, 2022, 53(8):2729-2738.
CAO X Y, FU Y L, XIE N N, et al. Inhibitory effect and mechanism of endogenous activation of angiotensin converting enzyme 2 by diminazene aceturate on cell lipid deposition[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(8):2729-2738. (in Chinese)
[22] YANG Y B, LI T Y, LI Z B, et al. Role of mitophagy in cardiovascular disease[J]. Aging Dis, 2020, 11(2):419-437.
[23] 文禹粱, 刘秀, 王继卿, 等. 哺乳动物线粒体动力学和氧化磷酸化研究进展[J]. 畜牧兽医学报, 2021, 52(2):273-285.
WEN Y L, LIU X, WANG J Q, et al. Research progress of mitochondrial dynamics and oxidative phosphorylation in mammal[J]. Acta Veterinaria et Zootechnica Sinica, 2021, 52(2):273-285. (in Chinese)
[24] GALLOWAY C A, YOON Y. Mitochondrial morphology in metabolic diseases[J]. Antioxid Redox Signal, 2013, 19(4):415-430.
[25] ZORZANO A, LIESA M, SEBASTIÁN D, et al. Mitochondrial fusion proteins:dual regulators of morphology and metabolism[J]. Semin Cell Dev Biol, 2010, 21(6):566-574.
[26] 丁志敏, 高静, 苏凯奇, 等. 线粒体质量控制体系介导缺血性脑卒中的康复及药物治疗研究进展[J]. 中华老年心脑血管病杂志, 2022, 24(12):1342-1344.
DING Z M, GAO J, SU K Q, et al. Research progress of mitochondrial quality control system mediating rehabilitation and drug therapy of ischemic stroke[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2022, 24(12):1342-1344. (in Chinese)
[27] SANTOS J M, TEWARI S, GOLDBERG A F X, et al. Mitochondrial biogenesis and the development of diabetic retinopathy[J]. Free Radic Biol Med, 2011, 51(10):1849-1860.
[28] HOUTEN S M, AUWERX J. PGC-1α:turbocharging mitochondria[J]. Cell, 2004, 119(1):5-7.
[29] SCHREIBER S N, EMTER R, HOCK M B, et al. The estrogen-related receptor α (ERRα) functions in PPARγ coactivator 1α (PGC-1α)-induced mitochondrial biogenesis[J]. Proc Natl Acad Sci U S A, 2004, 101(17):6472-6477.
[30] ANNESLEY S J, FISHER P R. Mitochondria in health and disease[J]. Cells, 2019, 8(7):680.
[31] VERCELLINO I, SAZANOV L A. The assembly, regulation and function of the mitochondrial respiratory chain[J]. Nat Rev Mol Cell Biol, 2022, 23(2):141-161.
[32] PUIGSERVER P, WU Z D, PARK C W, et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis[J]. Cell, 1998, 92(6):829-839.
[33] GARCÍA-BERUMEN C I, ORTIZ-AVILA O, VARGAS-VARGAS M A, et al. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria[J]. Lipids Health Dis, 2019, 18(1):78.
[34] MANUCHA W, RITCHIE B, FERDER L. Hypertension and insulin resistance:implications of mitochondrial dysfunction[J]. Curr Hypertens Rep, 2015, 17(1):504.